[Source: Journal of Clinical Virology, full page: (LINK). Abstract, edited.]
Journal of Clinical Virology | Available online 14 October 2020, 104661 | In Press, Journal Pre-proof
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China
Chunliang Lei 1, Weiyin Lin 1, Xilong Deng 1, Fengyu Hu 1, Fengjuan Chen, Weiping Cai, Yueping Li, Chunyan Wen, Yujuan Guan, JianWang, Xiaoting Chen, Yi Cao, Feng Li, Xiaoping Tang, Linghua Li, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510060, China
Received 19 August 2020, Accepted 10 October 2020, Available online 14 October 2020.
DOI: https://doi.org/10.1016/j.jcv.2020.104661
Highlights
- We retrospectively included 297 hospitalized patients with COVID-19, and explore virological and immunological factors associated with clinical outcomes.
- 23.0 % (62/270) of COVID-19 patients were detectable for SARS-CoV-2 RNA in annal swabs and/or blood samples, higher in severe/critical cases than in mild/moderate cases (52.0 % vs. 16.4 %, P < 0.001). The CD4/CD8 ratio was higher in severe/critical cases than in mild/moderate cases (1.84 vs. 1.50, P = 0.022).
- During a median follow-up period of 17 days, 36 (12.1 %) patients were admitted to intensive care unit (ICU), 16 (5.4 %) patients developed respiratory failure and underwent mechanical ventilation, four (1.3 %) patients needed extracorporeal membrane oxygenation (ECMO), one (0.34 %) patients died of multiple organ failure.
- Detectable viral RNA in anal swabs and/or blood samples and higher CD4/CD8 ratio were independent risk factors of respiratory failure and ICU admission. Screening the extrapulmonary virus, close monitoring of lymphocyte subsets among COVID-19 patients are needed.
Abstract
Background
Coronavirus Disease 2019 (COVID-19) is threatening billions of people. We described the clinical characteristics and explore virological and immunological factors associated with clinical outcomes.
Methods
297 COVID-19 patients hospitalized in Guangzhou Eighth People’s Hospital between January 20 and February 20, 2020 were included. Epidemiological, clinical and laboratory data were collected and analyzed. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in respiratory tract, blood samples and digestive tract was detected and lymphocyte subsets were tested periodically.
Result
Among the 297 patients (median age of 48 years), 154 (51.9 %) were female, 245 (82.5 %) mild/moderate cases, and 52 (17.5 %) severe/critical cases. 270 patients were detected for SARS-CoV-2 RNA in anal swabs and/or blood samples, and the overall positive rate was 23.0 % (62/270), higher in severe/critical cases than in mild/moderate cases (52.0 % vs. 16.4 %, P < 0.001). The CD4/CD8 ratio on admission was significantly higher in severe/critical cases than in mild/moderate cases (1.84 vs. 1.50, P = 0.022). During a median follow-up period of 17 days, 36 (12.1 %) patients were admitted to intensive care unit (ICU), 16 (5.4 %) patients developed respiratory failure and underwent mechanical ventilation, four (1.3 %) patients needed extracorporeal membrane oxygenation (ECMO), only one (0.34 %) patients died of multiple organ failure. Detectable SARS-CoV-2 RNA in anal swabs and/or blood samples, as well as higher CD4/CD8 ratio were independent risk factors of respiratory failure and ICU admission.
Conclusions
Most of COVID-19 patients in Guangzhou are mild/moderate, and presence of extrapulmonary virus and higher CD4/CD8 ratio are associated with higher risk of worse outcomes.
–
Keywords: SARS-CoV-2; COVID-19; Guangdong; China.
——
You must be logged in to post a comment.